{"id":2962,"date":"2026-09-01T09:40:04","date_gmt":"2026-09-01T09:40:04","guid":{"rendered":"https:\/\/pevropeptides.com\/?post_type=product&#038;p=2962"},"modified":"2026-09-02T16:15:02","modified_gmt":"2026-09-02T16:15:02","slug":"cjc-1295-zonder-dac-ipamorelin","status":"publish","type":"product","link":"https:\/\/pevropeptides.com\/sk\/product\/cjc-1295-zonder-dac-ipamorelin\/","title":{"rendered":"CJC-1295 bez DAC + Ipamorel\u00edn"},"content":{"rendered":"<p>Ten\/T\u00e1\/To <strong>CJC-1295 bez DAC + Ipamorel\u00edn<\/strong>-blend je vopred namie\u0161an\u00e1 kombinovan\u00e1 injek\u010dn\u00e1 liekovka, v ktorej s\u00fa dva sekretag\u00f3gy rastov\u00e9ho horm\u00f3nu (molekuly stimuluj\u00face uvo\u013e\u0148ovanie) kombinovan\u00e9 v pevnom pomere 1:1: CJC-1295 bez DAC (Mod GRF 1-29), anal\u00f3g GHRH (anal\u00f3g horm\u00f3nu uvo\u013e\u0148uj\u00faceho rastov\u00fd horm\u00f3n), a Ipamorel\u00edn, selekt\u00edvny agonista receptora ghrel\u00ednu. Oba peptidy p\u00f4sobia na hypof\u00fdzov\u00fa os prostredn\u00edctvom r\u00f4znych sign\u00e1lnych dr\u00e1h a \u010dasto sa spolo\u010dne sk\u00famaj\u00fa v laborat\u00f3rnom v\u00fdskume. Tento produkt je ur\u010den\u00fd v\u00fdhradne na vedeck\u00fd v\u00fdskum.<\/p>\n<h2>\u010co sa nach\u00e1dza v tejto zmesi?<\/h2>\n<p>Injek\u010dn\u00e1 liekovka obsahuje oba peptidy v pomere 1:1, vopred zmie\u0161an\u00e9 tak, aby boli po rekon\u0161tit\u00facii dostupn\u00e9 v jednom roztoku. K dispoz\u00edcii s\u00fa dve koncentr\u00e1cie: <strong>5 mg + 5 mg<\/strong> a <strong>10 mg + 10 mg<\/strong> na injek\u010dn\u00fa liekovku.<\/p>\n<ul>\n<li><strong><a href=\"https:\/\/lumopeptides.com\/product\/cjc-1295-no-dac\/\" target=\"_blank\" rel=\"noopener\">CJC-1295 bez DAC (Mod GRF 1-29)<\/a><\/strong> je modifikovan\u00fd fragment 29 aminokysel\u00edn GHRH. \u0160tyri aminokyselinov\u00e9 substit\u00facie (v poz\u00edci\u00e1ch 2, 8, 15 a 27) robia molekulu odolnej\u0161ou vo\u010di enzymatickej degrad\u00e1cii ako nemodifikovan\u00fd GRF(1-29). Vo v\u00fdskumn\u00fdch modeloch sa sk\u00fama jeho v\u00e4zba na receptor GHRH v hypof\u00fdze.<\/li>\n<li><strong><a href=\"https:\/\/lumopeptides.com\/product\/ipamorelin\/\" target=\"_blank\" rel=\"noopener\">Ipamorel\u00edn<\/a><\/strong> je selekt\u00edvny pentapeptid (Aib-His-D-2-Nal-D-Phe-Lys-NH\u2082), ktor\u00fd p\u00f4sob\u00ed na ghrel\u00ednov\u00fd alebo sekretag\u00f3gov\u00fd receptor rastov\u00e9ho horm\u00f3nu (GHS-R). Vo v\u00fdskume je zn\u00e1my svojou selektivitou vo\u010di pr\u00edbuzn\u00fdm sekretag\u00f3gom.<\/li>\n<\/ul>\n<h2>Zd\u00f4vodnenie kombin\u00e1cie vo v\u00fdskume<\/h2>\n<p>Tieto dve zlo\u017eky cielia na r\u00f4zne receptory a sign\u00e1lne dr\u00e1hy. Mod GRF 1-29 sa via\u017ee na receptor GHRH, zatia\u013e \u010do Ipamorel\u00edn aktivuje receptor ghrel\u00ednu. V predklinick\u00fdch \u0161t\u00fadi\u00e1ch sa toto p\u00e1rovanie pou\u017e\u00edva na sk\u00famanie toho, ako s\u00fa\u010dasn\u00e1 aktiv\u00e1cia oboch dr\u00e1h ovplyv\u0148uje pulzatiln\u00e9 uvo\u013e\u0148ovanie endog\u00e9nneho rastov\u00e9ho horm\u00f3nu z hypof\u00fdzy. T\u00e1to kombin\u00e1cia anal\u00f3gu GHRH a agonistu receptora ghrel\u00ednu sa v literat\u00fare pova\u017euje za klasick\u00fd model na \u0161t\u00fadium synergie medzi t\u00fdmito dvoma dr\u00e1hami uvo\u013e\u0148ovania a n\u00e1slednou osou IGF-1.<\/p>\n<h2>\u0160pecifik\u00e1cie<\/h2>\n<p><strong>CJC-1295 bez DAC (Mod GRF 1-29)<\/strong><\/p>\n<table>\n<thead>\n<tr>\n<th>\u0160pecifik\u00e1cia<\/th>\n<th>Hodnota<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Vzorka<\/td>\n<td>CJC-1295 bez DAC (Mod GRF 1-29)<\/td>\n<\/tr>\n<tr>\n<td>Synonym\u00e1<\/td>\n<td>Modifikovan\u00fd GRF (1-29); tetrasubstituovan\u00fd GRF (1-29); bez CJC-1295 DAC<\/td>\n<\/tr>\n<tr>\n<td>Molekul\u00e1rny vzorec \/ hmotnos\u0165<\/td>\n<td>C\u2081\u2085\u2082H\u2082\u2085\u2082N\u2084\u2084O\u2084\u2082 \/ \u00b1 3367,9 g\/mol<\/td>\n<\/tr>\n<tr>\n<td>Aminokyseliny<\/td>\n<td>29 (modifikovan\u00fd fragment GRF)<\/td>\n<\/tr>\n<tr>\n<td>Formul\u00e1r<\/td>\n<td>Lyofilizovan\u00fd pr\u00e1\u0161ok \u2013 5 mg alebo 10 mg na injek\u010dn\u00fa liekovku<\/td>\n<\/tr>\n<tr>\n<td>\u010cistota<\/td>\n<td>\u2265 99 % (HPLC)<\/td>\n<\/tr>\n<tr>\n<td>Skladovanie<\/td>\n<td>Chladno a tma; dlhodobo pri -20 \u00b0C<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Ipamorel\u00edn<\/strong><\/p>\n<table>\n<thead>\n<tr>\n<th>\u0160pecifik\u00e1cia<\/th>\n<th>Hodnota<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Vzorka<\/td>\n<td>Ipamorel\u00edn<\/td>\n<\/tr>\n<tr>\n<td>Synonym\u00e1<\/td>\n<td>NNC 26-0161<\/td>\n<\/tr>\n<tr>\n<td>\u010c\u00edslo CAS<\/td>\n<td>170851-70-4<\/td>\n<\/tr>\n<tr>\n<td>Molekul\u00e1rny vzorec \/ hmotnos\u0165<\/td>\n<td>C\u2083\u2088H\u2084\u2089N\u2089O\u2085 \/ 711,9 g\/mol<\/td>\n<\/tr>\n<tr>\n<td>PubChem CID<\/td>\n<td>9831659<\/td>\n<\/tr>\n<tr>\n<td>Postupnos\u0165<\/td>\n<td>Aib-His-D-2-Nal-D-Phe-Lys-NH\u2082<\/td>\n<\/tr>\n<tr>\n<td>Formul\u00e1r<\/td>\n<td>Lyofilizovan\u00fd pr\u00e1\u0161ok \u2013 5 mg alebo 10 mg na injek\u010dn\u00fa liekovku<\/td>\n<\/tr>\n<tr>\n<td>\u010cistota<\/td>\n<td>\u2265 99 % (HPLC)<\/td>\n<\/tr>\n<tr>\n<td>Skladovanie<\/td>\n<td>Chladno a tma; dlhodobo pri -20 \u00b0C<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Tvar, manipul\u00e1cia a skladovanie<\/h2>\n<p>Dod\u00e1va sa ako lyofilizovan\u00fd biely pr\u00e1\u0161ok v uzavretej liekovke. Neotvoren\u00fa liekovku skladujte na chladnom a tmavom mieste; pri dlhodobom skladovan\u00ed je vo v\u00fdskumn\u00fdch prostrediach be\u017en\u00e9 skladovanie pri teplote -20 \u00b0C. Po rekon\u0161tit\u00facii s vhodn\u00fdm rozp\u00fa\u0161\u0165adlom skladujte liekovku v chladni\u010dke (2 \u2013 8 \u00b0C) a vyh\u00fdbajte sa vystaveniu svetlu. S materi\u00e1lom manipulujte v\u00fdlu\u010dne s vhodn\u00fdm laborat\u00f3rnym vybaven\u00edm a v s\u00falade s platn\u00fdmi bezpe\u010dnostn\u00fdmi predpismi.<\/p>\n<h2>\u010cistota a laborat\u00f3rne v\u00fdsledky<\/h2>\n<p>Oba peptidy s\u00fa pon\u00fakan\u00e9 s kontrolovanou \u010distotou \u2265 99 %. Analytick\u00e9 certifik\u00e1ty a zodpovedaj\u00face laborat\u00f3rne v\u00fdsledky s\u00fa k dispoz\u00edcii na na\u0161ej <a href=\"https:\/\/lumopeptides.com\/labresultaten\/\" target=\"_blank\" rel=\"noopener\">str\u00e1nka s v\u00fdsledkami laborat\u00f3rnych testov<\/a>.<\/p>\n<h2>\u010casto kladen\u00e9 ot\u00e1zky<\/h2>\n<p><strong>\u010co znamen\u00e1 \u201ebez DAC\u201c?<\/strong> DAC (Drug Affinity Complex) je pr\u00edsada, ktor\u00e1 predl\u017euje \u010das cirkul\u00e1cie CJC-1295 v modeloch. Vo variante bez DAC t\u00e1to pr\u00edsada ch\u00fdba, \u010do sp\u00f4sobuje, \u017ee profil je bli\u017e\u0161ie k profilu nespracovan\u00e9ho fragmentu GRF(1-29). T\u00ed, ktor\u00ed h\u013eadaj\u00fa variant s dlhodob\u00fdm \u00fa\u010dinkom, ho n\u00e1jdu ako <a href=\"https:\/\/lumopeptides.com\/product\/cjc-1295-met-dac\/\" target=\"_blank\" rel=\"noopener\">CJC-1295 s DAC<\/a>.<\/p>\n<p><strong>Pre\u010do s\u00fa tieto dve pon\u00fakan\u00e9 spolu?<\/strong> Ke\u010f\u017ee p\u00f4sobia prostredn\u00edctvom r\u00f4znych receptorov, vo v\u00fdskume sa \u010dasto sk\u00famaj\u00fa ako p\u00e1r. Podobn\u00e9 usporiadanie s anal\u00f3gom GHRH a agonistom ghrel\u00ednov\u00e9ho receptora je... <a href=\"https:\/\/lumopeptides.com\/product\/tesamorelin-11mg-ipamorelin-6mg\/\" target=\"_blank\" rel=\"noopener\">Tesamorel\u00edn + Ipamorel\u00edn<\/a>-zmes.<\/p>\n<p><strong>Ako sa pr\u00e1\u0161ok rekon\u0161tituuje?<\/strong> Rekon\u0161tit\u00facia vo v\u00fdskumn\u00fdch zariadeniach sa zvy\u010dajne vykon\u00e1va pomocou bakteriostatickej vody, ktor\u00e1 sa pomaly prid\u00e1va k stene liekovky. Netrasie sa; pr\u00e1\u0161ok sa pomaly rozp\u00fa\u0161\u0165a do \u010d\u00edreho roztoku.<\/p>\n<p class=\"lumo-blogcta\"><strong>Chcete sa dozvedie\u0165 viac?<\/strong> Pre\u010d\u00edtajte si n\u00e1\u0161ho sprievodcu: <a href=\"https:\/\/lumopeptides.com\/hgh-peptiden-ghrh-ghrp-uitgelegd\/\" target=\"_blank\" rel=\"noopener\">Vysvetlenie HGH peptidov: anal\u00f3gy GHRH, GHRP a rozdiel od skuto\u010dn\u00e9ho rastov\u00e9ho horm\u00f3nu<\/a>.<\/p>\n<p><em>Ur\u010den\u00e9 v\u00fdhradne na laborat\u00f3rne a v\u00fdskumn\u00e9 \u00fa\u010dely. Nie je ur\u010den\u00e9 na \u013eudsk\u00fa ani \u017eivo\u010d\u00ed\u0161nu spotrebu, ani na lek\u00e1rske, diagnostick\u00e9, terapeutick\u00e9 alebo kozmetick\u00e9 pou\u017eitie. Kupuj\u00faci m\u00e1 viac ako 18 rokov a potvrdzuje v\u00fdskumn\u00fd kontext. Nie je to liek.<\/em><\/p>","protected":false},"excerpt":{"rendered":"<p><strong data-start=\"671\" data-end=\"751\">CJC-1295 bez DAC + Ipamorel\u00edn \u2013 kombin\u00e1cia peptidov pre v\u00fdskumn\u00e9 aplik\u00e1cie<\/strong><br data-start=\"751\" data-end=\"754\" \/>CJC-1295 bez DAC a Ipamorel\u00edn spolu tvoria syntetick\u00fa peptidov\u00fa kombin\u00e1ciu pou\u017e\u00edvan\u00fa v laborat\u00f3rnych a predklinick\u00fdch v\u00fdskumn\u00fdch prostrediach. Obe molekuly sa pou\u017e\u00edvaj\u00fa v \u0161t\u00fadi\u00e1ch zameran\u00fdch na interakcie receptorov a sign\u00e1lne dr\u00e1hy. T\u00e1to kombin\u00e1cia nie je ur\u010den\u00e1 ako medic\u00ednsky, terapeutick\u00fd alebo spotrebite\u013esk\u00fd produkt a pou\u017e\u00edvaj\u00fa ju v\u00fdlu\u010dne odborn\u00edci vo v\u00fdskumnom prostred\u00ed.<\/p>","protected":false},"featured_media":3317,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[129,124],"product_tag":[],"class_list":["post-2962","product","type-product","status-publish","has-post-thumbnail","product_cat-blends","product_cat-musculoskeletaal-onderzoek","first","instock","shipping-taxable","purchasable","product-type-variable"],"_links":{"self":[{"href":"https:\/\/pevropeptides.com\/sk\/wp-json\/wp\/v2\/product\/2962","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pevropeptides.com\/sk\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/pevropeptides.com\/sk\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/pevropeptides.com\/sk\/wp-json\/wp\/v2\/comments?post=2962"}],"version-history":[{"count":1,"href":"https:\/\/pevropeptides.com\/sk\/wp-json\/wp\/v2\/product\/2962\/revisions"}],"predecessor-version":[{"id":3033,"href":"https:\/\/pevropeptides.com\/sk\/wp-json\/wp\/v2\/product\/2962\/revisions\/3033"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pevropeptides.com\/sk\/wp-json\/wp\/v2\/media\/3317"}],"wp:attachment":[{"href":"https:\/\/pevropeptides.com\/sk\/wp-json\/wp\/v2\/media?parent=2962"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/pevropeptides.com\/sk\/wp-json\/wp\/v2\/product_brand?post=2962"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/pevropeptides.com\/sk\/wp-json\/wp\/v2\/product_cat?post=2962"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/pevropeptides.com\/sk\/wp-json\/wp\/v2\/product_tag?post=2962"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}